Structure and immunological action of the human pathogen Moraxella catarrhalis IgD-binding protein

Critical Reviews in Immunology

Volumn 26, Issue 4, 2006, Pages 353-376

  Riesbeck, Kristian ^a   Nordström, Therése ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Bacteria; Moraxella catarrhalis; Nonimmune Ig binding; Respiratory pathogen

Indexed keywords

B LYMPHOCYTE RECEPTOR; BACTERIAL ANTIGEN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN D BINDING PROTEIN; OUTER MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY COMBINING SITE; B LYMPHOCYTE; BACTERIAL INFECTION; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; EPITHELIUM CELL; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HELPER CELL; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMORAL IMMUNITY; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; MOLECULAR INTERACTION; MORAXELLA CATARRHALIS; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

EID: 33748882336     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevimmunol.v26.i4.40     Document Type: Review

References (148)

1. Doern GV, Morse SA. Branhamella (Neisseria) catarrhalis: criteria for laboratory identification. J Clin Microbiol. 1980;11:193-5.
2. Faden H, Harabuchi Y, Hong JJ. Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media. J Infect Dis. 1994;169:1312-7.
3. Van Hare GF, Shurin PA, Marchant CD, Cartelli NA, Johnson CE, Fulton D, Carlin S, Kim CH. Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Rev Infect Dis. 1987;9:16-27.
4. Ejlertsen T, Thisted E, Ebbesen F, Olesen B, Renneberg J. Branhamella catarrhalis in children and adults. A study of prevalence, time of colonisation, and association with upper and lower respiratory tract infections. J Infect. 1994;29:23-31.
5. Verduin CM, Hol C, Fleer A, van Dijk H, van Belkum A. Moraxella catarrhalis: from emerging to established pathogen. Clin Microbiol Rev. 2002;15:125-44.
6. Ejlertsen T, Thisted E, Ostergaard PA, Renneberg J. Maternal antibodies and acquired serological response to Moraxella catarrhalis in children determined by an enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol. 1994;1:464-8.
7. Pelton SI, Klein JO. The promise of immunoprophylaxis for prevention of acute otitis media. Pediatr Infect Dis J3. 1999;18:926-35.
8. Wald ER. Sinusitis in children. N Engl J Med. 1992;326:319-23.
9. Blumer J. Clinical perspectives on sinusitis and otitis media. Pediatr Infect Dis J. 1998;17:S68-72.
10. Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-theart review. Clin Microbiol Rev. 2001;14:336-63.
11. Sethi S. Bacterial infection and the pathogenesis of COPD. Chest. 2000;117:286S-91S.
12. Pollard JA, Wallace Jr RJ, Nash DR, Luman JI, Wilson RW. Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease. Drugs. 1986;31:103-8.
13. Schalén L, Christensen P, Kamme C, Miorner H, Pettersson KI, Schalén C. High isolation rate of Branhamella catarrhalis from the nasopharynx in adults with acute laryngitis. Scand J Infect Dis. 1980;12:277-80.
14. Riley TV. Antimicrobial resistance in Branhamella catarrhalis. J Antimicrob Chemother. 1988;21:147-50.
15. McGregor K, Chang BJ, Mee BJ, Riley TV. Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases. Eur J Clin Microbiol Infect Dis. 1998;17:219-34.
16. Brook I. Direct and indirect pathogenicity of Branhamella catarrhalis. Drugs. 1986;31 Suppl 3:97-102.
17. Hol C, van Dijke EE, Verduin CM, Verhoef J, van Dijk H. Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia. J Infect Dis. 1994;170:1613-6.
18. Jeurissen A, Ceuppens JL, Bossuyt X. T lymphocyte dependence of the antibody response to T lymphocyte independent type 2′ antigens. Immunology. 2004;111:1-7.
19. Mond JJ, Lees A, Snapper CM. T cell-independent antigens type 2. Annu Rev Immunol. 1995;13:655-92.
20. Vos Q, Lees A, Wu ZO, Snapper CM, Mond JJ. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev. 2000;176:154-70.
21. Brunswick M, June CH, Finkelman FD, Dintzis HM, Inman JK, Mond JJ. Surface immunoglobulin-mediated B-cell activation in the absence of detectable elevations in intracellular ionized calcium: a model for T-cell-independent B-cell activation. Proc Natl Acad Sci U S A. 1989;86:6724-8.
22. Snow EC. Handbook of B and T lymphocytes. London: Academic Press; 1994. p. 343-70.
23. Mosier DE, Mond JJ, Goldings EA. The ontogeny of thymic independent antibody responses in vitro in normal mice and mice with an X-linked B cell defect. J Immunol. 1977;119:1874-8.
24. Williams N. T cells on the mucosal frontline. Science. 1998;280:198-200.
25. Neron S, Lemieux R. CD5+ B cell-dependent regulation of the murine T-cell independent immune response against the human blood group A antigen. Immunol Invest. 1997;26:631-47.
26. Dintzis RZ, Vogelstein B, Dintzis HM. Specific cellular stimulation in the primary immune response: experimental test of a quantized model. Proc Natl Acad Sci U S A. 1982;79:884-8.
27. Dintzis HM, Dintzis RZ, Vogelstein B. Molecular determinants of immunogenicity: the immunon model of immune response. Proc Natl Acad Sci U S A. 1976;73:3671-5.
28. Lesinski GB, Westerink MA. Novel vaccine strategies to T-independent antigens. J Microbiol Methods. 2001;47:135-49.
29. Obukhanych TV, Nussenzweig MC. T-independent type II immune responses generate memory B cells. J Exp Med. 2006;203:305-10.
30. Forsgren A, Sjöquist J. "Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin. J Immunol. 1966;97:822-7.
31. Kronvall G, Williams Jr RC. Differences in antiprotein A activity among IgG subgroups. J Immunol. 1969;103:828-33.
32. Inganäs M. Comparison of mechanisms of interaction between protein A from Staphylococcus aureus and human monoclonal IgG, IgA and IgM in relation to the classical FC gamma and the alternative F(ab')2 epsilon protein A interactions. Scand J Immunol. 1981;13:343-52.
33. Deisenhofer J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. Biochemistry. 1981;20:2361-70.
34. Uhlen M, Guss B, Nilsson B, Gatenbeck S, Philipson L, Lindberg M. Complete sequence of the staphylococcal gene encoding protein A. A gene evolved through multiple duplications. J Biol Chem. 1984;259:1695-702.
35. Sakurada J, Li Z, Seki K, Murai M, Usui A, Morihigashi M, Jitsukawa H, Seong HK, Mutou M, Masuda S. Biochemical and genetic heterogeneity of staphylococcal protein A. FEMS Microbiol Lett. 1994;119:59-63.
36. Roben PW, Salem AN, Silverman GJ. VH3 family antibodies bind domain D of staphylococcal protein A. J Immunol. 1995;154:6437-45.
37. Zhang L, Jacobsson K, Vasi J, Lindberg M, Frykberg L. A second IgG-binding protein in Staphylococcus aureus. Microbiology. 1998;144:985-91.
38. Björck L, Kronvall G. Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J Immunol. 1984;133:969-74.
39. Erntell M, Myhre EB, Kronvall G. Non-immune IgG F(ab')2 binding to group C and G streptococci is mediated by structures on gamma chains. Scand J Immunol. 1985;21:151-7.
40. Derrick JP, Wigley DB. Crystal structure of a streptococcal protein G domain bound to an Fab fragment. Nature. 1992;359:752-4.
41. Guss B, Eliasson M, Olsson A, Uhlen M, Frej AK, Jornvall H, Flock JI, Lindberg M. Structure of the IgG-binding regions of streptococcal protein G. EMBO J. 1986;5:1567-75.
42. Erntell M, Myhre EB, Sjöbring U, Bjorck L. Streptococcal protein G has affinity for both Fab- and Fc-fragments of human IgG. Mol Immunol. 1988;25:121-6.
43. Frick IM, Wikström M, Forsen S, Drakenberg T, Gomi H, Sjöbring U, Björck L. Convergent evolution among immunoglobulin G-binding bacterial proteins. Proc Natl Acad Sci U S A. 1992;89:8532-6.
44. Björck L. Protein L. A novel bacterial cell wall protein with affinity for Ig L chains. J Immunol. 1988;140:1194-7.
45. Åkerström B, Björck L. Protein L: an immunoglobulin light chain-binding bacterial protein. Characterization of binding and physicochemical properties. J Biol Chem. 1989;264:19740-6.
46. Nilson BH, Solomon A, Björck L, Åkerstrom B. Protein L from Peptostreptococcus magnus binds to the kappa light chain variable domain. J Biol Chem. 1992;267:2234-9.
47. Kastern W, Sjöbring U, Björck L. Structure of peptostreptococcal protein L and identification of a repeated immunoglobulin light chain-binding domain. J Biol Chem/. 1992;267:12820-5.
48. Gronenborn AM, Filpula DR, Essig NZ, Achari A, Whitlow M, Wingfield PT, Clore GM. A novel, highly stable fold of the immunoglobulin binding domain of streptococcal protein G. Science. 1991;253:657-61.
49. Wikström M, Drakenberg T, Forsen S, Sjöbring U, Björck L. Three-dimensional solution structure of an immunoglobulin light chain-binding domain of protein L. Comparison with the IgG-binding domains of protein G. Biochemistry. 1994;33:14011-7.
50. Lindahl G, Åkerström B. Receptor for IgA in group A streptococci: cloning of the gene and characterization of the protein expressed in Escherichia coli. Mol Microbiol. 1989;3:239-47.
51. Johnsson E, Andersson G, Lindahl G, Heden LO. Identification of the IgA-binding region in streptococcal protein Arp. J Immunol. 1994;153:3557-64.
52. Åkesson P, Cooney J, Kishimoto F, Björck L. Protein H - a novel IgG binding bacterial protein. Mol Immunol. 1990;27:523-31.
53. Stenberg L, O'Toole PW, Mestecky J, Lindahl G. Molecular characterization of protein Sir, a streptococcal cell surface protein that binds both immunoglobulin A and immunoglobulin G. J Biol Chem. 1994;269:13458-64.
54. Johnsson E, Areschoug T, Mestecky J, Lindahl G. An IgA-binding peptide derived from a streptococcal surface protein. J Biol Chem. 1999;274:14521-4.
55. Nielsen K, Duncan JR. Demonstration that nonspecific bovine Brucella abortus agglutinin is EDTA-labile and not calcium dependent. J. Immunol. 1982;129:366.
56. Widders PR, Smith JW, Yarnall M, McGuire TC, Corbeil LB. Non-immune immunoglobulin binding by "Haemophilus somnus." J Med Microbiol. 1988;26:307-11.
57. Widders PR, Dorrance LA, Yarnell M, Corbeil LB. Immunoglobulin-binding activity among pathogenic and carrier isolates of Haemophilus somnus. Infect Immun. 1989;57:639.
58. Widders PR, Stokes CR, Newby TJ, Bourne FJ. Nonimmune binding of equine immunoglobulin by the causative organism of contagious equine metritis, Taylorella equigenitalis. Infect Immun. 1985;48:417.
59. Sandt CH, Hill CW. Nonimmune binding of human immunoglobulin A (IgA) and IgG Fc by distinct sequence segments of the EibF cell surface protein of Escherichia coli. Infect Immun. 2001;69:7293-303.
60. Sandt CH, Wang YD, Wilson RA, Hill CW. Escherichia coli strains with nonimmune immunoglobulin-binding activity. Infect Immun. 1997;65:4572-9.
61. Forsgren A, Brant M, Möllenkvist A, Muyombwe A, Janson H, Woin N, Riesbeck K. Isolation and characterization of a novel IgD-binding protein from Moraxella catarrhalis. J Immunol. 2001;167:2112-20.
62. Möllenkvist A, Nordström T, Hallden C, Christensen JJ, Forsgren A, Riesbeck K. The Moraxella catarrhalis immunoglobulin D-binding protein MID has conserved sequences and is regulated by a mechanism corresponding to phase variation. J Bacteriol. 2003;185:2285-95.
63. Forsgren A, Grubb A. Many bacterial species bind human IgD. J Immunol. 1979;122:1468-72.
64. Munson RS, Sasaki K. Protein D, a putative immunoglobulin D-binding protein produced by Haemophilus influenzae, is glycerophosphodiester phosphodiesterase. J Bacteriol. 1993;175:4569-71.
65. Pleass RJ, Areschoug T, Lindahl G, Woof JM. Streptococcal IgA-binding proteins bind in the Calpha 2-Calpha 3 interdomain region and inhibit binding of IgA to human CD89. J Biol Chem. 2001;276:8197-204.
66. Berge A, Kihlberg BM, Sjöholm AG, Björck L. Streptococcal protein H forms soluble complement-activating complexes with IgG, but inhibits complement activation by IgG-coated targets. J Biol Chem. 1997;272:20774-81.
67. Malmheden Yman I, Stålenheim G, Sjöquist J. The effect of C4 on C1 binding and activation. Scand J Immunol. 1982;15:587-93.
68. Silverman GJ. B-cell superantigens. Immunol Today. 1997;18:379-86.
69. Kristiansen SV, Pascual V, Lipsky PE. Staphylococcal protein A induces biased production of Ig by VH3-expressing B lymphocytes. J Immunol. 1994;153:2974-82.
70. Axcrona K, Björck L, Leanderson T. Multiple ligand interactions for bacterial immunoglobulin-binding proteins on human and murine cells of the hematopoietic lineage. Scand J Immunol. 1995;42:359-67.
71. GjöWingren A, Hadzic R, Forsgren A, Riesbeck K. A novel IgD-binding bacterial protein from Moraxella catarrhalis induces human B lymphocyte activation and isotype switching in the presence of Th2 cytokines. J Immunol. 2002;168:5583-8.
72. Silverman GJ, Goodyear CS. A model B-cell superantigen and the immunobiology of B lymphocytes. Clin Immunol. 2002;102:117-34.
73. Rowe DS, Fahey JL. A new class of human immunoglobulins. II. Normal serum IgD. J Exp Med. 1965;121:185-99.
74. Rowe DS, Fahey JL. A new class of human immunoglobulins. I. A unique myeloma protein. J Exp Med. 1965;121:171-84.
75. Takahashi N, Neel JV, Satoh C, Nishizaki, Masunari N. A phylogeny for the principal alleles of the human phosphoglucomutase-1 locus. Proc Natl Acad Sci U S A. 1982;79:6636-40.
76. Gala FA, Morrison SL. The role of constant region carbohydrate in the assembly and secretion of human IgD and IgA1. J Biol Chem. 2002;277:29005-11.
77. Griffiths RW, Gleich GJ. Proteolytic degradation of IgD and its relation to molecular conformation. J Biol Chem. 1972;247:4543-8.
78. Rogentine GN, Rowe DS, Bradley J, Waldmann TA, Fahey JL. Metabolism of human immunoglobulin D (IgD). J Clin Invest. 1966;45:1467-78.
79. Putnam FW, Putman FW, Takahashi N, Tetaert D, Debuire B, Lin LC. Amino acid sequence of the first constant region domain and the hinge region of the delta heavy chain of human IgD. Proc Natl Acad Sci U S A. 1981;78:6168-72.
80. Brandtzaeg P, Johansen FE. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev. 2005;206:32-63.
81. Surjan L, Brandtzaeg P, Berdal P. Immunoglobulin systems of human tonsils. II. Patients with chronic tonsillitis or tonsillar hyperplasia: quantification of Ig-producing cells, tonsillar morphometry and serum Ig concentrations. Clin Exp Immunol. 1978;31:382-90.
82. Litwin SD, Zehr BD. In vitro studies on human IgD. I. Sources and characteristics of "externalized" IgD in tonsil lymphocyte cultures. Eur J Immunol. 1987;17:483-9.
83. Sorensen CH, Larsen PL. IgD in nasopharyngeal secretions and tonsils from otitis-prone children. Clin Exp Immunol. 1988;73:149-54.
84. Sorensen CH. Quantitative aspects of IgD and secretory immunoglobulins in middle ear effusions. Int J Pediatr Otorhinolaryngol. 1983;6:247-53.
85. Miller RD, Gleich GJ, Offord KP, Dunnette SL. Immunoglobulin concentrations in serum and nasal secretions in chronic obstructive pulmonary disease. A matched-pair study. Am Rev Respir Dis. 1979;119:229-38.
86. Van Boxel JA, Paul WE, Terry WD, Green I. Communications. IgD-bearing human lymphocytes. J Immunol. 1972;109:648-51.
87. Kim KM, Reth M. The B cell antigen receptor of class IgD induces a stronger and more prolonged protein tyrosine phosphorylation than that of class IgM. J Exp Med. 1995;181:1005-14.
88. Carsetti R, Kohler G, Lamers MC. A role for immunoglobulin D: interference with tolerance induction. Eur J Immunol. 1993;23:168-78.
89. Kim KM, Yoshimura T, Watanabe H, Ishigami T, Nambu M, Hata D, Higaki Y, Sasaki M, Tsutsui T, Mayumi M, Mikawa H. Growth regulation of a human mature B cell line, B104, by anti-IgM and anti-IgD antibodies. J Immunol. 1991;146:819-25.
90. Tisch R, Roifman CM, Hozumi N. Functional differences between immunoglobulins M and D expressed on the surface of an immature B-cell line. Proc Natl Acad Sci U S A. 1988;85:6914-8.
91. Norvell A, Monroe JG. Acquisition of surface IgD fails to protect from tolerance-induction. Both surface IgM- and surface IgD-mediated signals induce apoptosis of immature murine B lymphocytes. J Immunol. 1996;156:1328-32.
92. Roes J, Rajewsky K. Immunoglobulin D (IgD)-deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells. J Exp Med. 1993;177:45-55.
93. Nitschke L, Kosco MH, Kohler G, Lamers MC. Immunoglobulin D-deficient mice can mount normal immune responses to thymus-independent and -dependent antigens. Proc Natl Acad Sci U S A. 1993;90:1887-91.
94. Lutz C, Ledermann B, Kosco-Vilbois MH, Ochsenbein AF, Zinkernagel RM, Kohler G, Brombacher F. IgD can largely substitute for loss of IgM function in B cells. Nature. 1998;393:797-801.
95. Banck G, Forsgren A. Many bacterial species are mitogenic for human blood B lymphocytes. Scand J Immunol. 1978;8:347-54.
96. Forsgren A, Banck G, Grubb A. Bacteria-immunoglobulin-lymphocyte interactions - new aspects. Scand J Infect Dis. 1980;24:112-8.
97. Ruan MR, Akkoyunlu M, Grubb A, Forsgren A. Protein D of Haemophilus influenzae. A novel bacterial surface protein with affinity for human IgD. J Immunol. 1990;145:3379-84.
98. Sasaki K, Munson Jr RS. Protein D of Haemophilus influenzae is not a universal immunoglobulin D-binding protein. Infect Immun. 1993;61:3026-31.
99. Janson H, Hedén LO, Grubb A, Ruan M, Forsgren A. Protein D, an immunoglobulin D-binding protein of Haemophilius influenzae: cloning, nucleotide sequence, and expression in Escherichia coli. Infect Immun. 1991;59:119-25.
100. Janson H, Melhus Å, Hermansson A, Forsgren A. Protein D, the glycerophosphodiester phosphodiesterase from Haemophilus influenzae with affinity for human immunoglobulin D, influences virulence in a rat otitis model. Infect Immun. 1994;62:4848-54.
101. Janson H, Carlén B, Cervin A, Forsgren A, Björk-Magnusdottir A, Lindberg S, Runer T. Effects on the ciliated epithelium of protein D-producing and -nonproducing nontypeable Haemophilus influenzae in nasopharyngeal tissue cultures. J Infect Dis. 1999;180:737-46.
102. Poolman JT, Bakaletz L, Cripps A, Denoel PA, Forsgren A, Kyd J, Lobet Y. Developing a nontypeable Haemophilus influenzae (NTHi) vaccine. Vaccine. 2000;19:S108-15.
103. Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, Kohl I, Lommel P, Poolman J, Prieels JP, Schuerman L. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet. 2006;367:740-8.
104. Forsgren A, Penta A, Schlossman SF, Tedder TF. Branhamella catarrhalis activates human B lymphocytes following interactions with surface IgD and class I major histocompatibility complex antigens. Cell Immunol. 1988;112:78-88.
105. Aebi C, Lafontaine ER, Cope LD, Latimer JL, Lumbley SL, McCracken GH, Hansen EJ. Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis 035E. Infect Immun. 1998;66:3113-9.
106. Forsgren A, Brant M, Karamehmedovic M, Riesbeck K. The immunoglobulin D-binding protein MID from Moraxella catarrhalis is also an adhesion. Infect Immun. 2003;71:3302-9.
107. Henderson IR, Owen P, Nataro JP. Molecular switches - the ON and OFF of bacterial phase variation. Mol Microbiol. 1999;33:919-32.
108. Salaun L, Snyder LA, Saunders NJ. Adaptation by phase variation in pathogenic bacteria. Adv Appl Microbiol. 2003;52:263-301.
109. Van der Woude MW, Baumler AJ. Phase and antigenic variation in bacteria. Clin Microbiol Rev. 2004;17:581-611.
110. Fitzgerald M, Mulcahy R, Keane C, Coakley D, Scott T. Transmission electron microscopy studies of Moraxella (Branhamella) catarrhalis. FEMS Immunol Med Microbiol. 1999;23:57-66.
111. Lafontaine ER, Wagner NJ, Hansen EJ. Expression of the Moraxella catarrhalis UspA1 protein undergoes phase variation and is regulated at the transcriptional level. J Bacteriol. 2001;183:1540-51.
112. Lafontaine ER, Cope LD, Aebi C, Latimer JL, McCracken Jr GH, Hansen EJ. The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro. J Bacteriol. 2000;182:1364-73.
113. Henderson IR, Navarro-Garcia F, Desvaux M, Fernandez RC, Ala'Aldeen D. Type V protein secretion pathway: the autotransporter story. Microbiol Mol Biol Rev. 2004;68:692-744.
114. Cotter SE, Surana NK, St Geme JW III. Trimeric autotransporters: a distinct subfamily of autotransporter proteins. Trends Microbiol. 2005;13:199-205.
115. Desvaux M, Parham NJ, Henderson IR. The autotransporter secretion system. Res Microbiol. 2004;155:53-60.
116. Schulz GE. β-Barrel membrane proteins. Curr Opin Struct Biol. 2000;10:443-7.
117. Schulz GE. The structure of bacterial outer membrane proteins. Biochim Biophys Acta. 2002;1565:308-17.
118. Schulz GE. Transmembrane β-barrel proteins. Adv Protein Chem. 2003;63:47-70.
119. Maurer J, Jose J, Meyer TF. Characterization of the essential transport function of the AIDA-I autotransporter and evidence supporting structural predictions. J Bacteriol. 1999;181:7014-20.
120. Suzuki T, Lett MC, Sasakawa C. Extracellular transport of VirG protein in Shigella. J Biol Chem. 1995;270:30874-80.
121. Shannon JL, Fernandez RC. The C-terminal domain of the Bordetella pertussis autotransporter BrkA forms a pore in lipid bilayer membranes. J Bacteriol. 1999;181:5838-42.
122. Veiga E, Sugawara E, Nikaido H, de Lorenzo V, Fernandez LA. Export of autotransported proteins proceeds through an oligomeric ring shaped by C-terminal domains. EMBO J. 2002;21:2122-31.
123. Surana NK, Cutter D, Barenkamp SJ, St Geme JW. The Haemophilus influenzae Hia autotransporter contains an unusually short trimeric translocator domain. J Biol Chem. 2004;279:14679-85.
124. Hoiczyk E, Roggenkamp A, Reichenbecher M, Lupas A, Heesemann J. Structure and sequence analysis of Yersinia YadA and Moraxella UspAs reveal a novel class of adhesins. EMBO J. 2000;19:5989-99.
125. Wollmann P, Zeth K, Lupas AN, Linke D. Purification of the YadA membrane anchor for secondary structure analysis and crystallization. Int J Biol Macromol. 2006;39:3-9.
126. Nordström T, Forsgren A, Riesbeck K. The immunoglobulin D-binding part of the outer membrane protein MID from Moraxella catarrhalis comprises 238 amino acids and a tetrameric structure. J Biol Chem. 2002;277:34692-9.
127. Åkerström B, Lindahl G, Björck L, Lindqvist A. Protein Arp and protein H from group A streptococci. Ig binding and dimerization are regulated by temperature. J Immunol. 1992;148:3238-43.
128. Smith CA, Pangburn MK, Vogel CW, Muller-Eberhard HJ. Molecular architecture of human properdin, a positive regulator of the alternative pathway of complement. J Biol Chem. 1984;259:4582-8.
129. Pangburn MK. Analysis of the natural polymeric forms of human properdin and their functions in complement activation. J Immunol. 1989;142:202-7.
130. Bravo A, Gomez I, Conde J, Munoz-Garay C, Sanchez J, Miranda R, Zhuang M, Gill SS, Soberon M. Oligomerization triggers binding of a Bacillus thuringiensis Cry1Ab pore-forming toxin to aminopeptidase N receptor leading to insertion into membrane microdomains. Biochim Biophys Acta. 2004;1667:38-46.
131. Pearson MM, Lafontaine ER, Wagner NJ, St Geme JW III, Hansen EJ. A hag mutant of Moraxella catarrhalis strain O35E is deficient in hemagglutination, autoagglutination, and immunoglobulin D-binding activities. Infect Immun. 2002;70:4523-33.
132. Holm MM, Vanlerberg SL, Sledjeski DD, Lafontaine ER. The Hag protein of Moraxella catarrhalis strain O35E is associated with adherence to human lung and middle ear cells. Infect Immun. 2003;71:4977-84.
133. Bullard B, Lipski SL, Lafontaine ER. Hag directly mediates the adherence of Moraxella catarrhalis to human middle ear cells. Infect Immun. 2005;73:5127-36.
134. Sasaki K, Harkness RE, Klein MH. Nucleic acids encoding high molecular weight major outer membrane protein of Moraxella. U.S. Patent 1998;5,808,024.
135. Forsgren A, Brant M, Riesbeck K. Immunization with the truncated adhesin moraxella catarrhalis immunoglobulin D-binding protein (MID764-913) is protective against M. catarrhalis in a mouse model of pulmonary clearance. J Infect Dis. 2004;190:352-5.
136. Calvert JE, Calogeras A. Characteristics of human B cells responsive to the T-independent mitogen Branhamella catarrhalis. Immunology. 1986;58:37-41.
137. Huston MM, Moore JP, Mettes HJ, Tavana G, Huston DP. Human B cells express IL-5 receptor messenger ribonucleic acid and respond to IL-5 with enhanced IgM production after mitogenic stimulation with Moraxella catarrhalis. J Immunol. 1996;156:1392-401.
138. Nordström T, Jendholm J, Samuelsson M, Forsgren A, Riesbeck K. The IgD-binding domain of the Moraxella IgD-binding protein MID (MID962-1200) activates human B cells in the presence of T cell cytokines. J Leukoc Biol. 2006;79:319-29.
139. Rogers KA, Richardson JP, Scinicariello F, Attanasio R. Molecular characterization of immunoglobulin D in mammals: immunoglobulin heavy constant delta genes in dogs, chimpanzees and four old world monkey species. Immunology. 2006;118:88-100.
140. Hadzic R, Forsgren A, Cardell LO, Riesbeck K, Wingren AG. The CD19 molecule is crucial for MID-dependent activation of tonsillar B cells from children. Scand J Immunol. 2005;61:165-72.
141. Wilson R, Dowling RB, Jackson AD. The biology of bacterial colonization and invasion of the respiratory mucosa. Eur Resir J. 1996;9:1523-30.
142. Mongini PK, Stein KE, Paul WE. T cell regulation of IgG subclass antibody production in response to T-independent antigens. J Exp Med. 1981;153:1-12.
143. Brandtzaeg P, Gjeruldsen ST, Korsrud F, Baklien K, Berdal P, Ek J. The human secretory immune system shows striking heterogeneity with regard to involvement of J chain-positive IgD immunocytes. J Immunol. 1979;122:503-10.
144. Hanson LA, Brandtzaeg P. The mucosal defense system. In: Stiehm ER, Fulginiti VA, editors. Immunological disorders in infants and children. London: Saunders; 1980. p. 137.
145. Sørensen CH. Quantitative aspects of IgD and secretory immunoglobulins in middle ear effusions. Int J Pediatr Otorhinolaryngol. 1983;6:247-53.
146. Sørensen CH, Larsen PL. IgD in nasopharyngeal secretions and tonsils from otitis-prone children. Clin Exp Immunol. 1988;73:149-54.
147. Lindahl G, Kronvall G. Nonimmune binding of Ig to Clostridium perfringens. Preferential binding of IgM and aggregated IgG. J Immunol. 1988;140:1223-7.
148. Russell-Jones GJ, Gotschlich EC, Blake MS. A surface receptor specific for human IgA on group B streptococci possessing the Ibc protein antigen. J Exp Med. 1984;160:1467-75.